Status: Not yet recruiting
Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)
Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure
Participants needed: 500
Trial details
Phase: Phase 2, Phase 3Age: 10-80Biological sex: AllType: InterventionalSponsor: Ebima Clifford OkundayeUpdated: Feb 18, 2026Locations: 1
Eligibility criteria
Hospitalized patients [+3]